Life Sciences

  • Microbiome / Nutrition / Foodtech / Lifestyle
  • Medtech / Connected health / Digital health
  • Biotech & pharmaceuticals
  • Industrial Biotech & Cleantech
  • Animal health / Animal Feed & Nutrition

Read more

Digital Technologies

  • Fintech
  • Retailtech
  • Other digital innovative solutions
  • Hardware & telecom

Read more

Sport & Performance Capital

  • Sport-Health
  • Equipment
  • Food-Nutrition
  • IOT-Digital
  • Sports practice

Read more

Blue Economy

  • Sustainable aquaculture
  • Nutrition Cosmetics Health
  • Industrial Products & Biomaterials
  • Biopolymers and biopackaging
  • Digitalization Blue 3.0
  • Recycling, Bioremediation
  • Climate & Carbon
  • Bioenergies, hydrogen

Read more

News

  • Water recycling: Chemdoc Water Technologies boosts its financial resources
    28 August 2024

    Water recycling: Chemdoc Water Technologies boosts its financial resources

    4.5 million euros. On July 10, Chemdoc Water...

  • Microbiotica’s Microbiome Medicines in Melanoma and Ulcerative Colitis Gain Regulatory Approvals in EU and UK for Phase 1b Studies
    27 August 2024

    Microbiotica’s Microbiome Medicines in Melanoma and Ulcerative Colitis Gain Regulatory Approvals in EU and UK for Phase 1b Studies

    Microbiotica’s Microbiome Medicines in Melanoma and...

  • Biotech: why Singapore’s Allozymes is setting up its European subsidiary in Toulouse
    21 August 2024

    Biotech: why Singapore’s Allozymes is setting up its European subsidiary in Toulouse

    Allozymes, a leading innovator in the discovery and...

  • Fierce Biotech Names Tubulis a “Fierce 15” Biotech Company of 2024
    5 August 2024

    Fierce Biotech Names Tubulis a “Fierce 15” Biotech Company of 2024

    Tubulis announced today that Fierce Biotech has named...

    Read more...
  • CITRYLL ANNOUNCES COMPLETION OF PATIENT ENROLMENT AND DOSING IN THE REPEAT DOSING STAGE OF THE PHASE 1 TRIAL FOR THE NOVEL ANTI-INFLAMMATORY DRUG, CIT-013
    31 July 2024

    CITRYLL ANNOUNCES COMPLETION OF PATIENT ENROLMENT AND DOSING IN THE REPEAT DOSING STAGE OF THE PHASE 1 TRIAL FOR THE NOVEL ANTI-INFLAMMATORY DRUG, CIT-013

    Citryll, a clinical-stage biotech company developing...

    Read more...